Added to YB: 2025-03-27
Pitch date: 2025-03-25
PRPH [bullish]
ProPhase Labs, Inc.
-98.16%
current return
Author Info
No bio for this author
Company Info
ProPhase Labs, Inc. develops and commercializes novel drugs, dietary supplements, and compounds in the United States.
Market Cap
$972.5K
Pitch Price
$4.90
Price Target
N/A
Dividend
N/A
EV/EBITDA
N/A
P/E
N/A
EV/Sales
1.94
Sector
Pharmaceuticals
Category
special_situation
ProPhase Labs (PRPH): A $10M Company with Multi-Bagger Potential?
PRPH: $10M mkt cap, 5 assets worth multiples. CEO history of shareholder returns. Potential $50M settlement from Covid testing. Hired marketing guru for new products. Owns Nebula Genomics (full DNA sequencing). Developing esophageal cancer test. Possible telehealth launch. Catalysts: loan, litigation cash, Nebula sale/partnership, cancer test progress.
Read full article (4 min)